9results about How to "Improve constipation" patented technology

The invention discloses a low GI functional bread, and relates to the technical field of food processing. The low GI functional bread includes the following weight portions of cereal raw materials, auxiliary materials and fruit raw materials: 40-50 weight portions of barley, 20-25 weight portions of white highland barley, 15-25 weight portions of buckwheat; 10-15 weight portions of butter; 10-15 weight portions of salt; 0.75-1 weight portions of dry yeast; 5-9 weight portions of apples, and 5-11 weight portions of fresh peaches. The present invention also includes a preparation method of low GI functional bread. The present invention selects low GI content cereal raw materials and fruit raw materials to make low GI bread, which helps to relieve constipation, make people feel full, and improve the functionality of low GI bread; when the rotating roller is pressed in the groove, the sliding part is driven down under the action force of the reset spring, so that the sealing plate blocks the discharge port, and intermittent flour laying is realized on the conveyor belt, which effectively prevents the bread from being connected to the conveyor belt, improves work efficiency, and saves the use of flour.

The fructus cannabis paste comprises the following raw materials in parts by weight: 120 to 180 parts of fructus perillae, 280 to 320 parts of wheat, 200 to 240 parts of bulbus lilii, 125 to 175 parts of rhizoma dioscoreae, 50 to 100 parts of pericarpium citri reticulatae, 280 to 320 parts of fructus cannabis, 80 to 120 parts of semen armeniacae amarae, 180 to 220 parts of semen persicae, 180 to 220 parts of semen pruni, 180 to 220 parts of semen raphani, 30 to 40 parts of dried figs, 40 to 50 parts of pears and 25 to 35 parts of mulberries. The food has the advantages of quick effect and eating safety.

This invention discloses a guanylate cyclase-C (GC-C) activating peptide and its applications, belonging to the field of bioactive peptide technology. The amino acid sequence of the GC-C activating peptide is PFPGPIPN. The GC-C activating peptide of this invention can significantly activate GC-C activity, increasing intracellular cGMP levels. Furthermore, the GC-C activating peptide of this invention can alleviate constipation and abdominal pain symptoms in mice, thereby effectively preventing or improving irritable bowel syndrome (IBS). Therefore, the GC-C activating peptide provided by this invention has advantages such as high activity, safety and non-toxicity, and good water solubility. It can be used as a candidate molecule for alternative or adjuvant drugs in the clinical treatment of IBS, and also as a health product or food to improve constipation or abdominal pain.

This invention relates to a compound powder of highland barley seedlings for promoting bowel movements, its preparation method, and its applications. The raw materials include highland barley seedling powder, fructooligosaccharides, matcha powder, and compound probiotic powder. Excipients are then added to formulate it into solid beverages, compressed candies, jellies, and gummies. Animal experiments have verified that the compound powder of highland barley seedlings of this invention can significantly promote intestinal peristalsis and defecation in mice with constipation, effectively repair the intestinal immune barrier, significantly increase serum gastrin (MTL) levels, and significantly reduce vasoactive peptide (VIP) levels, thereby effectively improving constipation symptoms. The compound powder of highland barley seedlings of this invention is safe, readily available, and has no side effects. The components work synergistically, possessing a unique flavor and taste. It has significant bowel-regulating and laxative effects, and low doses are sufficient to achieve the desired effect, making it of great application value.

The utility model discloses a medical multifunctional prone position inflatable mattress, which relates to the technical field of medical mattresses and comprises an air cushion bed main body. An air cushion cotton cushion is installed on the upper surface of the air cushion bed body, an air pump is installed on the rear surface of the air cushion bed body, an air bag partition module is installed on the left side of the upper surface of the air pump, a pressure regulator is arranged on the right side of the upper surface of the air pump, and an inflation connector is arranged on the right side surface of the air cushion bed body. Compared with an existing common multifunctional medical prone-position mattress, the medical prone-position multifunctional inflatable mattress has the advantages that the first wedge-shaped air bag and the second wedge-shaped air bag are arranged, so that the medical prone-position multifunctional inflatable mattress is convenient to use; the body position of a patient can be assisted to turn over by 15-30 degrees by independently inflating and pressurizing the wedge-shaped air bag I and the wedge-shaped air bag II, so that the pressure of the whole body of the patient is relieved, the chest distress and suffocation symptoms of the patient are relieved and the constipation incidence rate is reduced on the basis that the traditional position of the patient after the spinal cord and spinal column operation is kept.

The present invention discloses a five-joint bacteria for conditioning and improving diarrhea, constipation and irritable bowel syndrome. The five-joint bacteria include Lactobacillus reuteri HBM11-69, Pediococcus pentosaceus MPL5, Lactobacillus plantarum La-10, Lactobacillus rhamnosus HBM11-35, and Lactobacillus casei C7-2. The strain was discovered by the team of Professor Lin Junfang of South China Agricultural University. The probiotic composition of the present invention cooperates with each other and synergizes to effectively restore the balance of intestinal flora structure by increasing the propulsion rate of the small intestine, reducing the number of diarrhea, etc. Whether it is a live bacteria or an inactivated state, it has a good improvement effect on gastrointestinal discomfort such as constipation and irritable bowel syndrome. The five-joint composite probiotics are highly safe, will not cause adverse reactions such as electrolyte imbalance, and can be used to prepare medicines or health foods or foods.

The invention provides a composition for constipation and a preparation method and application thereof.The composition is prepared from 130-140 parts of pumpkin powder, 30-35 parts of poria cocos powder, 40-50 parts of tremella powder, 80-90 parts of aloe powder and 80-90 parts of prebiotics. The preparation method of the composition for constipation comprises the following steps that 1, the pumpkin powder is prepared; step 2, preparing poria cocos powder; step 3, preparing tremella powder; step 4, preparing aloe powder; step 5, preparing the composition for treating constipation; uniformly mixing the pumpkin powder, the poria cocos powder, the tremella powder, the aloe powder and the prebiotics prepared in the steps 1-5 to prepare capsules, so as to obtain the composition for treating constipation. Through advanced processes of supercritical extraction, vacuum freeze drying, superfine grinding and the like, effective components in raw materials such as pumpkins, poria cocos, tremella fuciformis and aloe can be extracted and reserved to the maximum extent, and the pumpkin-poria cocos-aloe powder is suitable for being eaten for a long time.

The invention relates to the field of microorganisms, in particular to Akkermansia muciniphila YG2604, a microbial agent containing the Akkermansia muciniphila YG2604, a composition containing the Akkermansia muciniphila YG2604 and application of the Akkermansia muciniphila YG2604 and the microbial agent containing the Akkermansia muciniphila YG2604 and the composition containing the Akkermansia muciniphila YG2604 to preparation of products for preventing, improving and / or treating constipation. The ackermania muciniphila YG2604 disclosed by the invention can be used for maintaining the micro-ecological balance of intestinal tracts and effectively improving or treating constipation; moreover, the inactivated strain can realize the effects, and the inactivated strain product has better stability and longer shelf life, does not need cold-chain transportation and preservation, and is easier to commercialize and widely apply. Therefore, the Ackermania muciniphila YG2604 disclosed by the invention has a relatively good clinical application prospect and an obvious market potential.

The present invention belongs to the field of probiotics and its application technology, and is specifically related to a Lactobacillus paracasei XY6 and its application in preparing gastrointestinal conditioning and weight loss medicines. In order to dig out more Lactobacillus paracasei with probiotic functions, the present invention separates and purifies a Lactobacillus paracasei XY6 strain from a fecal sample of a healthy adult in Guangdong, and the strain can produce and secrete 3-hydroxybutyric acid, can inhibit α-glucosidase activity, can inhibit xanthine oxidase activity, has superior protease activity, has superior cellulase activity and can inhibit renin activity, has anti-inflammatory and improves intestinal flora; hypoglycemic; can prevent and alleviate multiple functions such as hyperuricemia and gout, and has important application value and economic value in the fields of gastrointestinal conditioning and weight loss.